PRGO logo

Perrigo Company plc (PRGO)

$16.18

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on PRGO

Market cap

$2.25B

EPS

-12.77

P/E ratio

--

Price to sales

0.5

Dividend yield

7.169%

Beta

0.721591

Price on PRGO

Previous close

$16.24

Today's open

$16.07

Day's range

$16.07 - $16.67

52 week range

$9.23 - $17.02

Profile about PRGO

CEO

Patrick Lockwood-Taylor

Employees

8100

Headquarters

Dublin 2,

Exchange

New York Stock Exchange

Shares outstanding

138801872

Issue type

Common Stock

PRGO industries and sectors

Consumer Staples

Consumer Products - Healthcare

News on PRGO

Perrigo to Attend the Jefferies Miami Consumer Conference

DUBLIN, Nov. 11, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra are scheduled to participate in investor meetings at the Jefferies Miami Consumer Conference on Wednesday, November 18, 2026. About Perrigo    Perrigo Company plc (NYSE: PRGO) is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.

news source

PRNewsWire • Nov 11, 2026

news preview

Perrigo Q3 Earnings Call Highlights

Perrigo NYSE: PRGO reported lower third-quarter sales and earnings as cautious retailer inventory decisions and weakness in Europe weighed on results, even as the self-care company gained market share and narrowed its core sales decline.

news source

MarketBeat • Nov 8, 2026

news preview

Perrigo: 3 Key Takeaways for Long-Term Investors

Perrigo agreed to divest its infant formula business. U.S. e-commerce reached 22% of Perrigo's U.S. volume.

news source

The Motley Fool • Nov 7, 2026

news preview

Perrigo Company plc (PRGO) Q3 2026 Earnings Call Transcript

Perrigo Company plc ( PRGO ) Q3 2026 Earnings Call November 4, 2026 8:30 AM EST Company Participants Eric Jacobson - Vice President of Global Investor Relations Albert Manzone - Interim President, Interim CEO & Director Eduardo Bezerra - Executive VP & CFO Conference Call Participants Susan Anderson - Canaccord Genuity Corp., Research Division Ethan Brown - JPMorgan Chase & Co, Research Division Presentation Operator Good morning ladies and gentlemen, and welcome to the Perrigo Third Quarter 2026 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Wednesday, November 4, 2026.

news source

Seeking Alpha • Nov 4, 2026

news preview

Perrigo Reports Third Quarter 2026 Financial Results From Continuing Operations

Execution of Three-S plan driving sequential improvement in operating results and market share gains across U.S. Store Brand OTC and key European brands Infant Formula divestiture expected to simplify portfolio and sharpen focus on higher-return consumer self care categories; strategic review of Oral Care business remains ongoing Updated full-year 2026 outlook to reflect divestiture, more measured retailer inventory positioning, and continued softness in Europe DUBLIN, Nov. 4, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or the "Company"), a leading provider of consumer self-care products, today announced financial results from continuing operations for the third quarter ended September 26, 2026. "Our Three-S plan is delivering continued progress in the areas of the business within our control," said Albert Manzone, Interim President and Chief Executive Officer.

news source

PRNewsWire • Nov 4, 2026

news preview

Perrigo (PRGO) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for Perrigo (PRGO) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

news source

Zacks Investment Research • Nov 4, 2026

news preview

Perrigo (PRGO) Surpasses Q3 Earnings Estimates

Perrigo (PRGO) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.8 per share a year ago.

news source

Zacks Investment Research • Nov 4, 2026

news preview

Perrigo Announces Quarterly Dividend

DUBLIN, Oct. 29, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that its Board of Directors has approved a quarterly dividend of $0.29 per share, or $1.16 per share on an annualized basis. The cash dividend is payable on December 15, 2026, to shareholders of record on November 27, 2026.

news source

PRNewsWire • Oct 29, 2026

news preview

Perrigo Announces Agreement to Divest Infant Formula Business to MeridianMade

Advances Streamline pillar of Perrigo's Three-S plan through portfolio simplification Furthers Perrigo's evolution into a simpler, more focused consumer self-care company Expected to enhance Perrigo's margin profile and eliminate significant expected future capital expenditures Aligns reported results more closely with the financial profile of Core Perrigo MeridianMade's infant-grade, American manufacturing infrastructure and operating capabilities will support the continued supply of safe, high-quality, and affordable infant nutrition DUBLIN, Oct. 29, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or "the Company"), a leading provider of consumer self-care products, today announced that it has entered into a definitive agreement pursuant to which MeridianMade, an American contract manufacturing platform dedicated to infant nutrition, will acquire Perrigo's Infant Formula business for total consideration of up to $175 million. The transaction consists of $40 million in cash at closing and up to an additional $135 million contingent on the achievement of future performance milestones through 2030.

news source

PRNewsWire • Oct 29, 2026

news preview

Earnings Preview: Perrigo (PRGO) Q3 Earnings Expected to Decline

Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

news source

Zacks Investment Research • Oct 28, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Perrigo Company plc

Open an M1 investment account to buy and sell Perrigo Company plc commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in PRGO on M1